26:19
Neoadjuvant therapy in Breast Cancer
Hope S. Rugo
Breast cancer is one of the best models showing how neoadjuvant therapy in defined molecular phenotypes leads to de-escalation of surgery and radiation therapies, and better selection of tre...
Breast cancer is one of the best models showing how neoadjuvant therapy in defined molecular phenotypes leads to de-escalation of surgery and radiation therapies, and better selection of treatment after surgery, including switching to a second line systemic therapy when patients don’t have a complete or near complete response to the first line neoadjuvant therapy.